Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO

Ekatherina Stoyanova, Marie Trudel, Hady Felfly, Wafaa Lemsaddek, Damien Garcia, Guy Cloutier, Ekatherina Stoyanova, Marie Trudel, Hady Felfly, Wafaa Lemsaddek, Damien Garcia, Guy Cloutier

Abstract

Aims: The hereditary β-thalassemia major condition requires regular lifelong blood transfusions. Transfusion-related iron overloading has been associated with the onset of cardiovascular complications, including cardiac dysfunction and vascular anomalies. By using an untransfused murine model of β-thalassemia major, we tested the hypothesis that vascular endothelial dysfunction, alterations of arterial structure and of its mechanical properties would occur despite the absence of treatments.

Methods and results: Vascular function and structure were evaluated ex vivo. Compared to the controls, endothelium-dependent vasodilation with acetylcholine was blunted in mesenteric resistance arteries of β-thalassemic mice while the endothelium-independent vasodilator (sodium nitroprusside) produced comparable vessel dilation, indicating endothelial cell impairment with preserved smooth muscle cell reactivity to nitric oxide (NO). While these findings suggest a decrease in NO bioavailability, Western blotting showed heightened expression of aortic endothelial NO synthase (eNOS) in β-thalassemia. Vascular remodeling of the common carotid arteries revealed increased medial elastin content. Under isobaric conditions, the carotid arteries of β-thalassemic mice exhibited decreased wall stress and softening due to structural changes of the vessel wall.

Conclusions: A complex vasculopathy was identified in untransfused β-thalassemic mice characterized by altered carotid artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced NO bioavailability despite enhanced vascular eNOS expression.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Vasodilatory responses of mesenteric resistance…
Figure 1. Vasodilatory responses of mesenteric resistance arterioles to acetylcholine (ACh) (A) and sodium nitroprusside (SNP) (B), in control (○; n = 10) and homo-βthal (•; n = 9) mice.
Relaxation responses are expressed as a percentage increase in lumen diameter after norepinephrine pre-contraction. Data are means ± SEM. *p<0.05.
Figure 2. Endothelium-dependent vasodilatory responses of mesenteric…
Figure 2. Endothelium-dependent vasodilatory responses of mesenteric resistance arterioles from control (n = 10) (A) and homo-βthal mice (n = 9) (B) to acetylcholine (ACh) in the absence (○) or presence (
) of L-NAME. Relaxation responses are expressed as a percentage increase in lumen diameter after norepinephrine pre-contraction. Data are means ± SEM. *p<0.05 and †p<0.001.
Figure 3. eNOS protein expression in aortae…
Figure 3. eNOS protein expression in aortae of control and homo-βthal mice.
(A) Representative Western blotting, and (B) densitometric analysis of eNOS protein expression (n = 6 mice per group). Measurements are expressed as % of eNOS bands in aortae of control mice. Data are means ± SEM. *p<0.05.
Figure 4. Comparison of structural characteristics in…
Figure 4. Comparison of structural characteristics in common carotid arteries from control (○; n = 13) and homo-βthal mice (•; n = 11).
(A) Luminal diameter, (B) external diameter, (C) wall cross-sectional area (CSA), and (D) wall-to-lumen ratio versus intraluminal pressure. Data are means ± SEM. †p<0.001.
Figure 5. Comparison of mechanical parameters in…
Figure 5. Comparison of mechanical parameters in common carotid arteries from control (○; n = 13) and homo-βthal mice (•; n = 11).
Circumferential strain-intraluminal pressure (A), circumferential stress-intraluminal pressure (B), and stress-strain (C) relationships. Data are means ± SEM. †p<0.001. The curve in panel C exhibits a rightward shift in the homo-βthal group, as shown by a significant decrease in β (p<0.01) and the slope of the tangential elastic strain modulus-to-stress relationship.
Figure 6. Histological analysis of elastin content…
Figure 6. Histological analysis of elastin content in media (A) and representative microscopy images of Verhoeff van Gieson-stained sections (B) of the left common carotid arteries in control (open bars) and homo-βthal mice (closed bars, n = 8 per group). Data are means ± SEM.
*p<0.05. L, vascular lumen.

References

    1. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127:1523–30.
    1. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2.
    1. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, et al. Cardiac status in well-treated patients with thalassemia major. European Journal of Haematology. 2004;73:359–66.
    1. Panigrahi I, Agarwal S. Thromboembolic complications in [beta]-thalassemia: beyond the horizon. Thrombosis Research. 2007;120:783–9.
    1. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99:36–43.
    1. Chen S, Eldor A, Barshtein G, Zhang S, Goldfarb A, et al. Enhanced aggregability of red blood cells of beta-thalassemia major patients. American Journal of Physiology. 1996;270:H1951–6.
    1. Hovav T, Goldfarb A, Artmann G, Yedgar S, Barshtein G. Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. British Journal of Haematology. 1999;106:178–81.
    1. Kyriakou DS, Alexandrakis MG, Kyriakou ES, Liapi D, Kourelis TV, et al. Activated peripheral blood and endothelial cells in thalassemia patients. Annals of Hematology. 2001;80:577–83.
    1. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, et al. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. American Journal of Hematology. 2002;70:100–6.
    1. Hahalis G, Kremastinos DT, Terzis G, Kalogeropoulos AP, Chrysanthopoulou A, et al. Global vasomotor dysfunction and accelerated vascular aging in [beta]-thalassemia major. Atherosclerosis. 2008;198:448–57.
    1. Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation. 2002;106:2561–6.
    1. Stakos DA, Tavridou A, Margaritis D, Tziakas DN, Kotsianidis I, et al. Oxidised low-density lipoprotein and arterial function in beta-thalassemia major. European Journal of Haematology. 2009;82:477–83.
    1. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. Journal of Clinical Investigation. 1998;101:731–6.
    1. Gedikli O, Altinbas A, Orucoglu A, Dogan A, Ozaydin M, et al. Elastic properties of the ascending aorta in patients with beta-thalassemia major. Echocardiography. 2007;24:830–6.
    1. Stakos DA, Margaritis D, Tziakas DN, Kotsianidis I, Chalikias GK, et al. Cardiovascular involvement in patients with [beta]-thalassemia major without cardiac iron overload. International Journal of Cardiology. 2009;134:207–11.
    1. Stoyanova E, Trudel M, Felfly H, Garcia D, Cloutier G. Characterization of circulatory disorders in beta-thalassemic mice by noninvasive ultrasound biomicroscopy. Physiological Genomics. 2007;29:84–90.
    1. Skow LC, Burkhart BA, Johnson FM, Popp RA, Popp DM, et al. A mouse model for beta-thalassemia. Cell. 1983;34:1043–52.
    1. Schiffrin EL, Hayoz D. How to assess vascular remodelling in small and medium-sized muscular arteries in humans. Journal of Hypertension. 1997;15:571–84.
    1. Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC. Heart failure in beta-thalassemia syndromes: a decade of progress. American Journal of Medicine. 2005;118:957–67.
    1. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program. 2008. pp. 177–85.
    1. Gladwin MT, Lancaster JR, Freeman BA, Schechter AN. Nitric oxide’s reactions with hemoglobin: a view through the SNO-storm. Nature Medicine. 2003;9:496–500.
    1. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. Journal of Clinical Investigation. 2005;115:3409–17.
    1. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA: Journal of the American Medical Association. 2005;294:81–90.
    1. Kassab-Chekir A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clinica Chimica Acta. 2003;338:79–86.
    1. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2005. pp. 51–7.
    1. Frei AC, Guo Y, Jones DW, Pritchard KA, Jr, Fagan KA, et al. Vascular dysfunction in a murine model of severe hemolysis. Blood. 2008;112:398–405.
    1. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA: Journal of the American Medical Association. 2005;293:1653–62.
    1. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood. 2007;109:3088–98.
    1. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:6770–4.
    1. Aggeli CJ, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. International Journal of Cardiology. 2005;105:80–4.
    1. Cheung YF, Chow PC, Chan GC, Ha SY. Carotid intima-media thickness is increased and related to arterial stiffening in patients with beta-thalassaemia major. British Journal of Haematology. 2006;135:732–4.
    1. Ulger Z, Aydinok Y, Gurses D, Levent E, Ozyurek AR. Stiffness of the abdominal aorta in beta-thalassemia major patients related with body iron load. Journal of Pediatric Hematology/Oncology. 2006;28:647–52.
    1. Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation. 2003;107:2601–6.
    1. Faller DV. Endothelial cell responses to hypoxic stress. Clinical and Experimental Pharmacology and Physiology. 1999;26:74–84.
    1. Fortuno A, Jose GS, Moreno MU, Diez J, Zalba G. Oxidative stress and vascular remodelling. Experimental Physiology. 2005;90:457–62.

Source: PubMed

3
Subscribe